Healthcare -
Biotechnology - NYSE - US
$ 13.185
-1.46 %
$ 1.21 B
Market Cap
-4.13
P/E
RCUS - COST OF REVENUE
Cost of Revenue RCUS - Arcus Biosciences, Inc.
340 M
LAST VALUE
594.11%
2 YEAR CAGR
46.93%
5 YEAR CAGR
0.00%
10 YEAR CAGR